L. Atahan Et Al. , "Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy," 31st Congress of the European-Society-for-Medical-Oncology , vol.17, İstanbul, Turkey, pp.80, 2006
Atahan, L. Et Al. 2006. Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy. 31st Congress of the European-Society-for-Medical-Oncology , (İstanbul, Turkey), 80.
Atahan, L., Yildiz, F., Gurkaynak, M., Ozyigit, G., & Hayran, M., (2006). Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy . 31st Congress of the European-Society-for-Medical-Oncology (pp.80). İstanbul, Turkey
Atahan, Lale Et Al. "Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy," 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 2006
Atahan, Lale Et Al. "Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, pp.80, 2006
Atahan, L. Et Al. (2006) . "Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, p.80.
@conferencepaper{conferencepaper, author={Lale Atahan Et Al. }, title={Percent positive axillary lymph node metastasis predicts loco-regional control and survival in patients with non-metastatic breast cancer receiving postoperative radiotherapy and chemotherapy}, congress name={31st Congress of the European-Society-for-Medical-Oncology}, city={İstanbul}, country={Turkey}, year={2006}, pages={80} }